組胺作為一種交感神經(jīng)遞質(zhì)的新證據(jù)
[Abstract]:Background and purpose
Histamine (HA) is an important autoactive substance in the human body. It has extensive physiological function and also participates in the pathophysiological process of mediating various diseases. In the central nervous system, there is a complete HA energy system, and HA as a central neurotransmitter is involved in mediating cognitive memory, sleeping awakening, drinking water intake and so on. In the peripheral group In the fabric, HA is mainly stored in two forms of mast cell source and non mast cell source. Mast cell derived HA is involved in the pathological process of mediating allergy. The physiological and pathological effects of non mast cell derived HA are not very clear. It has been found that non mast cell derived HA exists in the peripheral nerve of the stomach and intestines of the rat, and the superior cervical ganglion (Su Perior cervical ganglion, SCG), carotid body sensory neurons, etc., suggesting that HA may be associated with the activity of these neurons. Our previous study found that in the neurons of SCG of the guinea pig, the histamine acid decarboxylase (Histidine decarboxylase, HDC) and the tyrosine hydroxylase synthase of noradrenaline (Norepinephrine, NE) were involved in the SCG of the guinea pig. (Tyrosine hydroxylase, TH) coexist with the dopamine beta hydroxylase (Dobamine- beta -hydroxylase, D beta H), and both HA and NE coexist. Stimulating sympathetic nerve endings can release HA and NE from the sympathetic nerve endings. We first suggested that HA is likely to be a new sympathic neurotransmitter that has not yet been recognized, and proposes the hypothesis that HA participates in the negative feedback regulation of sympathetic neurotransmission. However, does the coexistence of HA and NE in sympathetic neurons are universal? What is the subcellular localization of HA in sympathetic neurons and whether HA is released from sympathetic neurons to follow the classics The release of neurotransmitter vesicles? These are questions that must be answered by the final definition of HA as a new sympathetic neurotransmitter. Based on the above problems, this study uses multiple immunofluorescence markers, anterograde tracing and laser confocal microscopy, to observe the sympathetic ganglion and sympathetic nerve endings of HA in different species of animals. Distribution and coexistence with NE; the subcellular localization of HA in sympathetic nerve endings and cultured sympathetic ganglion cells was observed by pre embedding immunoelectron microscopy, and on the primary cultured SCG cells of newborn guinea pigs, FM1-43 fluorescent dyes were used to study the release of HA synaptic vesicles and the kinetics of movement, which finally confirmed that HA was a new sympathetic nerve. The research in this field is of great theoretical significance to reveal the new function of sympathetic nerve, to understand the pathogenesis of the disease related to the disorder of sympathetic nervous disorder, and to find new potential therapeutic targets for potential treatment.
Result
1. coexistence of histamine and NE in the sympathetic nervous system of different animals
In this study, immunofluorescence double labeling and laser confocal microscopy were used to detect the coexistence of HA and NE in the sympathetic nerve endings of mice and guinea pigs and the sympathetic nerve terminals of the mesenteric arteries in mouse SCG, dog SCG and abdominal sympathetic ganglion neurons, and in the SCG of mice and dogs, the double standard rate of HA in the NE like immunoreactive neurons was respectively in mice and dogs. For 70% and 40%, the double standard rate of HA in NE like immun-positive neurons in the abdominal segment of the dog was 60%. in the vas deferens of mice and guinea pigs, and on the mesenteric artery specimens, the double standard rate of HA in the NE like immun-positive nerve fibers was 80% and 30%. respectively in the local microinjection of SCG in guinea pig SCG (Biotinylated dextranamine, BDA). A guinea pig heart specimen was taken to observe the HA. results in the sympathetic fibers and terminals projected from SCG to the heart by immunofluorescence three markers. The results showed that the BDA tracer projected into the sympathetic fibers of the heart, 20% of the tracer fibers were HA like immunoreactive, and 10% of the tracer fibers presented HA and NE like immunoreaction. The results indicated that HA was widely distributed in the sympathetic nervous system of different species of animals at the cellular level, and coexisted with NE, providing a direct morphological evidence for the definition of HA as a new sympathetic neurotransmitter.
2. subcellular localization of histamine in sympathetic nerve terminals and cultured SCG neurons
In the innervation of the sympathetic nerve endings of the guinea pig's vas deferens and the primary cultured guinea pig SCG neurons, the immuno electron microscopy showed that the HA like immunoreactive substance was located in the small vesicles with a diameter of about 50 nm, and that the HA positive vesicles accounted for more than 90% of the total vesicles, and the large vesicles (diameter 100 nm) and individual small vesicles were not H. A immunoreactive substances. The results showed that HA mainly existed in the vesicles of the sympathetic neurons. This result provides a direct morphological evidence for the definition of HA as a new sympathetic neurotransmitter at the subcellular level.
3. the kinetics of histamine synaptic vesicle circulation in SCG neurite outgrowth
Using FM1-43 fluorescent dye and HA immunofluorescence staining, the release kinetics of HA vesicles and the movement process of HA vesicles were observed on the SCG neurites in the cultured guinea pigs. The laser confocal microscope imaging and statistical analysis were made. The results of decolorization (Destaining) showed that the red fluorescence signal intensity of HA in the protuberance of the SCG God and the FM1-43 green in the protuberance of the SCG God. The intensity of the fluorescence signal increased with the increase of the depolarization time, and showed a gradual weakening. Both showed significant positive correlation (r = 0.989, P 0.01). It showed that the release of HA followed the general rule of the kinetics of vesicle release. The red fluorescence intensity and FM1-43 representing the HA were determined by the fixed cells at different time points of depolarization. The results of green fluorescence intensity indicate that the red fluorescence intensity of HA is stronger than the green fluorescence intensity of FM1-43. Due to the depolarization conditions used in this study, the FM1-43 fluorescence signal mainly reflects the release of circulating vesicles. The difference between the fluorescence intensity of HA and FM1-43 suggests that the vesicles stored on the HA at the nerve sites may exist. The results of Fluorescence recovery after photobleaching (FRAP) combined with immunohistochemical study showed that the diffusion rate of HA vesicles at SCG neurites was 0.09 u m2/s, and the other vesicles of 0.08 u m2/ s.HA vesicles were not significantly worse than other vesicles. Different.
Conclusion:
1. HA is ubiquitous in the sympathetic nervous system of many animals and coexists with the classical sympathetic neurotransmitter NE.
2. HA is mainly stored in the sympathetic synaptic vesicles.
The release of HA vesicles in 3. sympathetic neurons follows the classical neurotransmitter vesicle cycle dynamics. The storage of HA vesicles may be divided into release vesicles and reserve vesicles.
【學(xué)位授予單位】:第四軍醫(yī)大學(xué)
【學(xué)位級別】:博士
【學(xué)位授予年份】:2007
【分類號】:R363
【相似文獻】
相關(guān)期刊論文 前10條
1 黃順偉;金慧;管向東;;多巴胺和去甲腎上腺素在膿毒性休克中應(yīng)用的研究進展[J];醫(yī)學(xué)綜述;2011年11期
2 劉東順;李永;;序貫應(yīng)用去甲腎上腺素及大黃救治急性有機磷農(nóng)藥中毒60例[J];中國中醫(yī)急癥;2011年07期
3 王鵬飛;;支氣管擴張患者對沙丁胺醇和組胺的反應(yīng)性[J];中國社區(qū)醫(yī)師(醫(yī)學(xué)專業(yè));2011年23期
4 彭朝林;;去甲腎上腺素致狗髖關(guān)節(jié)一過性滑膜炎的機理研究[J];護理實踐與研究;2011年14期
5 戴龍芳;劉淮;;腎上腺素、去甲腎上腺素和促腎上腺皮質(zhì)釋放激素與妊娠期高血壓疾病[J];江西醫(yī)藥;2011年07期
6 幸曉燕;王青;周聯(lián);鄧向亮;;一種大鼠腹腔肥大細胞分離方法[J];免疫學(xué)雜志;2011年07期
7 唐文;蔣明德;徐輝;秦建平;沈才飛;;血漿置換聯(lián)合去甲腎上腺素治療重型肝炎合并Ⅱ型肝腎綜合征的臨床療效分析[J];北京醫(yī)學(xué);2011年09期
8 李建國;趙博;;中醫(yī)藥對抑郁癥單胺類神經(jīng)遞質(zhì)影響的研究進展[J];貴陽中醫(yī)學(xué)院學(xué)報;2011年04期
9 焦蓉;朱小燕;;心力衰竭患兒血漿神經(jīng)生長因子水平及卡托普利的干預(yù)研究[J];醫(yī)藥導(dǎo)報;2011年08期
10 高飛;麻樹人;張寧;宮照杰;孫亞男;楊卓;趙志峰;趙云峰;韓笑;;玻璃酸鈉、去甲腎上腺素、靛胭脂混合溶液在內(nèi)鏡黏膜下剝離術(shù)中的臨床應(yīng)用[J];解放軍醫(yī)學(xué)雜志;2011年07期
相關(guān)會議論文 前10條
1 李峰;劉小蘭;梁嶸;康純潔;楊維益;手紹良;瞿德弘;王天芳;陳家旭;趙建民;;中藥對人體疲勞后身心變化的調(diào)節(jié)作用[A];2002中醫(yī)藥博士論壇——中醫(yī)藥的繼承、創(chuàng)新與發(fā)展[C];2002年
2 吳金欣;;大黃去甲腎上腺素混懸劑搶救上消化道大出血18例療效觀察[A];中華醫(yī)學(xué)會全國第五次急診醫(yī)學(xué)學(xué)術(shù)會議論文集[C];1994年
3 陳慕雁;楊紅生;;應(yīng)激激素體外誘導(dǎo)對櫛孔扇貝血細胞活性的影響[A];中國海洋湖沼學(xué)會第九次全國會員代表大會暨學(xué)術(shù)研討會論文摘要匯編[C];2007年
4 許傳蓮;鄭毅男;韓立坤;奧田拓道;;大黃柳葉黃酮類成分促進脂肪分解作用的研究[A];首屆長三角科技論壇——長三角生物醫(yī)藥發(fā)展論壇論文集[C];2004年
5 宋閩寧;駱梅蘭;宋嶼娜;陳福;;急、慢性肝衰竭大鼠5-羥色胺、去甲腎上腺素對照研究[A];第五屆全國肝臟疾病臨床暨中華肝臟病雜志成立十周年學(xué)術(shù)會議論文匯編[C];2006年
6 羅昌霞;張建鄂;李濤;張慶紅;;維持性血透患者情感障礙和5-羥色胺、去甲腎上腺素水平的研究[A];中華醫(yī)學(xué)會腎臟病學(xué)分會2006年學(xué)術(shù)年會論文集[C];2006年
7 童玲;左科;楊穎;楊小軍;錢偉;侯曉華;;去甲腎上腺素在REM睡眠剝奪降低大鼠內(nèi)臟感覺功能中的作用[A];中華醫(yī)學(xué)會第七次全國消化病學(xué)術(shù)會議論文匯編(上冊)[C];2007年
8 唐文豪;閆龍濤;侯小飛;趙磊;王國良;黃毅;馬潞林;;后腹腔鏡左腎上腺區(qū)胃腸道外間質(zhì)瘤根治術(shù)[A];第十五屆全國泌尿外科學(xué)術(shù)會議論文集[C];2008年
9 陳慕雁;楊紅生;;應(yīng)激激素體外誘導(dǎo)對櫛孔扇貝血細胞活性的影響[A];中國動物學(xué)會、中國海洋湖沼學(xué)會貝類學(xué)分會第八次會員代表大會暨第十三次全國貝類學(xué)術(shù)討論會論文摘要集[C];2007年
10 黃俊龍;周江睿;馬騫;蔣春雷;;去甲腎上腺素通過toll樣受體4促進巨細胞炎癥因子的分泌[A];2008年神經(jīng)內(nèi)分泌暨神經(jīng)免疫內(nèi)分泌學(xué)術(shù)研討會論文摘要匯編[C];2008年
相關(guān)重要報紙文章 前10條
1 北京軍區(qū)總醫(yī)院主任醫(yī)師 張禹;去甲腎上腺素也可肌注[N];健康報;2001年
2 葉忠孝;吃魚:請嚴(yán)防組胺中毒[N];醫(yī)藥養(yǎng)生保健報;2006年
3 梁理;吃蟹四忌[N];中國食品質(zhì)量報;2003年
4 小漁;春季過敏有對策[N];中國醫(yī)藥報;2004年
5 鐘遠超;組胺H_(2)受體拮抗劑有望避免神經(jīng)元的缺血損害[N];醫(yī)藥導(dǎo)報;2004年
6 單曉聲;有些老人過年不能太激動[N];醫(yī)藥養(yǎng)生保健報;2009年
7 曉悅;吃蟹五忌[N];中國成人教育信息報;2000年
8 劉國信;哪些魚類食不得[N];大眾衛(wèi)生報;2000年
9 張曉穎;過敏性反應(yīng)病例分析(三)[N];農(nóng)村醫(yī)藥報(漢);2007年
10 ;是“誰”差不多每天同一時間喚醒我們?[N];新華每日電訊;2004年
相關(guān)博士學(xué)位論文 前10條
1 胡靜;組胺作為一種交感神經(jīng)遞質(zhì)的新證據(jù)[D];第四軍醫(yī)大學(xué);2007年
2 耿爽;SOC通道在組胺誘導(dǎo)的人樹突狀細胞介導(dǎo)的Th_2反應(yīng)中的作用研究[D];武漢大學(xué);2012年
3 田爽;去甲腎上腺素促進卵巢癌生長和血管化的分子機制以及使用PTD4-t4EBP2逆轉(zhuǎn)化療抵抗的實驗研究[D];第四軍醫(yī)大學(xué);2009年
4 儲敏;Ciproxifan對實驗動物睡眠—覺醒的影響及其作用機制研究[D];復(fù)旦大學(xué);2004年
5 黃俊龍;去甲腎上腺素通過toll樣受體4促進巨噬細胞炎癥因子的分泌[D];第二軍醫(yī)大學(xué);2008年
6 唐澤耀;肌球蛋白輕鏈的非Ca~(2+)依賴性磷酸化特征及其影響因素[D];大連醫(yī)科大學(xué);2005年
7 付作林;去甲腎上腺素在急性冬眠心肌中的釋放和作用[D];華中科技大學(xué);2006年
8 宋洪杰;皮膚組胺受體表達及西替利嗪的抗炎作用機制研究[D];第二軍醫(yī)大學(xué);2004年
9 陳?;藍斑對杏仁復(fù)合體神經(jīng)活動的影響及在學(xué)習(xí)記憶中的作用[D];華東師范大學(xué);2007年
10 汪俊;神經(jīng)生長因子啟動哮喘腎上腺髓質(zhì)細胞冗余性致腎上腺素釋放障礙及蛋白質(zhì)組學(xué)初步研究[D];中南大學(xué);2007年
相關(guān)碩士學(xué)位論文 前10條
1 胡榮;川芎揮發(fā)油解熱作用及機理研究[D];成都中醫(yī)藥大學(xué);2001年
2 肖榮;去甲腎上腺素對外周細胞炎性因子表達的影響[D];南華大學(xué);2007年
3 李愛莉;補腎寧心顆粒對實驗性焦慮模型大鼠腦組織中去甲腎上腺素、多巴胺影響的實驗研究[D];長春中醫(yī)藥大學(xué);2009年
4 冀永強;大鼠腦組織中去甲腎上腺素及腎上腺素濃度變化與尿毒癥腦病的關(guān)系[D];青島大學(xué);2005年
5 蔡萌;去甲腎上腺素對THP-1巨噬細胞SR-AI和ABCA1表達的影響[D];南華大學(xué);2005年
6 石磊;音樂療法對化療期白血病患者生理與焦慮狀態(tài)影響的研究[D];吉林大學(xué);2007年
7 曹漫明;組胺聯(lián)合白細胞介素2激活自體造血干細胞移植物[D];第一軍醫(yī)大學(xué);2000年
8 陳伯成;納洛酮和Orexins對麻醉大鼠前額葉皮層神經(jīng)元電活動的影響及其機制研究[D];第三軍醫(yī)大學(xué);2005年
9 薛麗;冰片對長時連續(xù)作業(yè)大鼠覺醒能力損害干預(yù)的神經(jīng)機制[D];第三軍醫(yī)大學(xué);2006年
10 喬愛秀;發(fā)育中小鼠胃內(nèi)組胺免疫反應(yīng)細胞的形態(tài)學(xué)研究[D];山西醫(yī)科大學(xué);2003年
,本文編號:2137252
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/2137252.html